2021
DOI: 10.1007/s10096-021-04382-4
|View full text |Cite
|
Sign up to set email alerts
|

Impact of FilmArray™ Respiratory Panel testing on the clinical management of pediatric bone marrow transplant patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 19 publications
0
4
0
Order By: Relevance
“…For instance, human coronavirus NL63 and 229E are detected using the nucleocapsid ( N ) gene; influenza A targets the matrix ( M ) gene, while influenza B targets the non-structural ( NS ) gene; human adenovirus targets the hexon gene; parainfluenza viruses 1–4 target the hemagglutinin-neuraminidase ( HN ) gene; both human coronavirus OC43 and RSV are identified through the N gene; human metapneumovirus targets the matrix ( M ) gene; coronavirus HKU1 targets the N gene; human rhinovirus/enterovirus is detected through the 5′ non-coding region (5′NCR); Middle East respiratory syndrome coronavirus utilizes the upstream of the E protein (UpE) and ORF1b genes; and SARS-CoV-2 often targets the ORF1ab , N , and spike ( S ) genes. In the PCR process of the BioFire respiratory panel 2.1, these targeted genes, represented by specific primers, are mixed in a single reaction, and their amplification signifies the presence of the respective pathogen in the sample [ 24 ]. It allows for the rapid detection of the causative virus [ 25 ].…”
Section: Methodsmentioning
confidence: 99%
“…For instance, human coronavirus NL63 and 229E are detected using the nucleocapsid ( N ) gene; influenza A targets the matrix ( M ) gene, while influenza B targets the non-structural ( NS ) gene; human adenovirus targets the hexon gene; parainfluenza viruses 1–4 target the hemagglutinin-neuraminidase ( HN ) gene; both human coronavirus OC43 and RSV are identified through the N gene; human metapneumovirus targets the matrix ( M ) gene; coronavirus HKU1 targets the N gene; human rhinovirus/enterovirus is detected through the 5′ non-coding region (5′NCR); Middle East respiratory syndrome coronavirus utilizes the upstream of the E protein (UpE) and ORF1b genes; and SARS-CoV-2 often targets the ORF1ab , N , and spike ( S ) genes. In the PCR process of the BioFire respiratory panel 2.1, these targeted genes, represented by specific primers, are mixed in a single reaction, and their amplification signifies the presence of the respective pathogen in the sample [ 24 ]. It allows for the rapid detection of the causative virus [ 25 ].…”
Section: Methodsmentioning
confidence: 99%
“…Of the 402 samples from patients with upper respiratory tract symptoms, 54% tested positive for a respiratory virus. Results from the rapid test also informed infection control measures for all inpatients and antiviral initiation in >80% of episodes with influenza [8].…”
Section: Standard Diagnosticsmentioning
confidence: 99%
“…Methods for rapid detection of viral respiratory infections have improved in recent times. The film array respiratory panel (FA-RP) detects 17 viral respiratory pathogens and the clinical utility was retrospectively analysed in 671 nasal swabs from 204 paediatric HSCT patients [8]. Of the 402 samples from patients with upper respiratory tract symptoms, 54% tested positive for a respiratory virus.…”
Section: Nasal Swabmentioning
confidence: 99%
“…[10][11][12] Studies evaluating clinical outcomes for children positive for HRV/ENT on RM-PCR testing remain limited, with analyses focusing on inpatient or clinical outcomes in specific populations. [13][14][15][16][17] A 2014 analysis of inpatient clinical measures demonstrated that children with HRV/ENT positivity on RM-PCR were likelier to be hospitalized and have more severe illnesses than those positive for other viruses. 18 An outpatient analysis evaluating the clinical and socioeconomic burden of HRV/ ENT positivity in adults and children revealed that under-17-yearolds positive for HRV/ENT on RM-PCR were likelier than adults to seek medical care.…”
mentioning
confidence: 99%